DMAAR
NASDAQ
US
Drugs Made In America Acquisition Corp. - Rights
N/A
· N/A
· IPO Jan 2025
$0.06
▲ +$0.00
(+0.00%)
Vol 29K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$347.7M
P/E
63.8
D/E
0.00
Beta
-0.79
52W
$10–$10
Price Chart
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | 63.55 | 63.83 |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.17 | 0.20 | 0.17 | 0.17 | 0.06 | 0.06 |
Key Ratios
ROA (TTM)
3.1%
EPS (TTM)
$0.20
52W High
$10.37
52W Low
$9.95
$9.95
52-Week Range
$10.37
How does DMAAR compare to N/A peers?
Peer group: Micro-cap N/A (All) · 453 companies
DMAAR valuation vs N/A peers
P/E ratio
63.8
▲
13%
above
peers
(56.5)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(6.0)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(1.3)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(19.6%)
vs Peers
vs Industry
Low yield
DMAAR profitability vs N/A peers
ROE
—
▼
0%
below
peers
(2.8%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(0.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(63.5%)
vs Peers
vs Industry
Weak
ROA
3.1%
▲
18%
above
peers
(2.6%)
vs Peers
vs Industry
Weak
DMAAR financial health vs N/A peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.1
▼
95%
below
peers
(1.1)
vs Peers
vs Industry
Low liquidity
Beta
-0.8
▼
4033%
below
peers
(0.0)
vs Peers
vs Industry
More volatile
DMAAR fundamentals radar
DMAAR
Peer median
Industry
DMAAR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
DMAAR vs peers: key metrics
Top Holders
Polar Asset Management Part…
$89K
Hudson Bay Capital Manageme…
$85K
Harraden Circle Investments…
$71K
Highbridge Capital Manageme…
$48K
Toronto Dominion Bank
$47K
As of Dec 31, 2025
Latest News
No related news yet